Worth Watching Stocks: ServiceNow, Inc. (NYSE:NOW), Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)


ServiceNow, Inc. (NYSE:NOW)

ServiceNow, Inc. (NYSE:NOW) represented a move of 3.45 percent or $-5.63 per share and closed its previous day trading session at $185.27. 3.13 Million Shares were traded in the last trading session with an Average Volume of 2.25 Million Shares. The stock currently has a Market Capitalization of 33.11 Billion.

ServiceNow, Inc. provides cloud-based services that automate enterprise IT operations. The Company’s service includes a suite of applications built on its platform that automates workflow and integrates related business processes. It focuses on transforming enterprise IT by automating and standardizing business processes and consolidating IT across the global enterprise. ServiceNow, Inc. is based in San Diego, California.

The stock traded between $112.84 and $206.29 over 1-Year time period showing its price to sales ratio of 13.57. ServiceNow, Inc. (NYSE:NOW) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.

Right now, the stock has a 50-Day Simple Moving Average of $3.31 and 200-Day Simple Moving Average of $4.09. Its Price to Free Cash Flow is 47.85 and Price to Book of 32.45.

Analyst’s recommended the stock as 1.8 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, ServiceNow, Inc. (NYSE:NOW) reported its Actual EPS of $0.68/share. The analysts offering Earnings Estimates for the company were believing that ServiceNow, Inc. could bring EPS of $0.6/share. The difference between Actual EPS and Estimated EPS was 0.08 Percent. Thus showing an Earnings Surprise of 13.3 Percent.

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)

In the last trading session, Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) added its value by 5.97% closing at the price of $47.42. The stock currently has market capitalization of 2.48 Billion, with average volume of 557.33 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) is showing beta of 0.94. This particular value of beta suggests that Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) has historically moved 94% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) is at $2.01.

The stock currently has RSI of 59.49. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) topped its 52-week high price of $61.25 on 06/29/18 and 52-Week Low Price of $34.90 on 02/09/18. The Stock currently has P/E (price to earnings ttm) of 23.59 and Weekly volatility of 4.08% and monthly volatility of 4.75% respectively.